To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Mativ Holdings (MATV) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +44.44%. A quarter ago, it was expected that this paper and reconstituted tobacco company would post earnings of $0.18 per share when it actually produced earnings of $0.33, delivering a surprise of +83.33%.Over the ...

RLJ Lodging (RLJ) came out with quarterly funds from operations (FFO) of $0.27 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to FFO of $0.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +3.85%. A quarter ago, it was expected that this hotel real estate investment trust would post FFO of $0.46 per share when it actually produced FFO of $0.48, delivering a surprise of +4.35%.Over the last four qu ...

RCM Technologies, Inc. (RCMT) came out with quarterly earnings of $0.42 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.67%. A quarter ago, it was expected that this company would post earnings of $0.61 per share when it actually produced earnings of $0.69, delivering a surprise of +13.11%.Over the last four quarters, the ...

U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1.49%. A quarter ago, it was expected that this physician staffing services company would post earnings of $0.71 per share when it actually produced earnings of $0.81, delivering a surprise of +14.08%.Over t ...

TriplePoint Venture Growth (TPVG) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.34%. A quarter ago, it was expected that this investment company would post earnings of $0.3 per share when it actually produced earnings of $0.28, delivering a surprise of -6.67%.Over the last four ...

Nissan Motor has concluded a 97 billion yen ($643 million) deal to sell and lease back its global headquarters in Yokohama, Japan, as part of its business restructuring plans, the automaker said on Th... ...

Core Insights - Elanco Animal Health Incorporated is a significant player in the animal health industry, focusing on enhancing animal care through various products and services [1] - The company is led by CEO Jeff Simmons, who emphasizes growth and maintaining a strong market position amidst competition [1] Financial Performance - Stifel Nicolaus has set a price target of $27 for Elanco, indicating a potential increase of approximately 23.26% from its current price of $21.91 [2][6] - The stock is currently trading at $21.94, reflecting a slight decrease of 2.49% with a change of $0.56 [2] - Elanco's stock has shown volatility, with a daily trading range from $21.38 to $22.98, and over the past year, it reached a high of $22.96 and a low of $8.02 [4] Market Position and Consumer Behavior - CEO Jeff Simmons highlighted that consumer willingness to spend on animal care remains strong even during challenging economic times, indicating stable demand for Elanco's products [3][6] - The company is focusing on resource allocation to sustain its market position and adapt to consumer trends [3] Market Capitalization and Trading Activity - Elanco maintains a market capitalization of approximately $10.9 billion, reflecting its substantial presence in the animal health industry [4][6] - The trading volume for ELAN is 9,189,975 shares, indicating active investor interest in the company's stock [5]

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased Baxter common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...